0 Yorumlar
0 hisse senetleri
1K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Pharmaceutical Contract Manufacturing Market Insights for Pharma CompaniesThe global Pharmaceutical Contract Manufacturing Market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, registering a CAGR of 10.4% from 2026 to 2033. North America accounted for the largest market share of 38.44% in 2025, supported by a mature pharmaceutical ecosystem, robust R&D investments, and...0 Yorumlar 0 hisse senetleri 42 Views 0 önizleme
-
Blow Fill Seal (BFS) Technology Market: Transforming Sterile Pharmaceutical Packaging Through Advanced Aseptic ManufacturingThe Global Blow Fill Seal (BFS) Technology Market is witnessing accelerated expansion as pharmaceutical manufacturers increasingly prioritize sterile, contamination-free, and high-efficiency packaging systems. Blow-fill-seal technology has evolved into one of the most reliable aseptic packaging methods for liquid pharmaceuticals, biologics, ophthalmic solutions, respiratory drugs, vaccines, and...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Europe Blow-Fill-Seal BFS Products Market Forecast Reaches USD 4.37 BillionAccording to a new report from Intel Market Research, the Europe BFS (Blow‑Fill‑Seal) Products market was valued at USD 2.01 billion in 2024 and is projected to grow from USD 2.24 billion in 2025 to USD 4.37 billion by 2032, exhibiting a robust CAGR of 11.5% during the forecast period (2025–2032). This expansion is driven by the continent’s mature pharmaceutical ecosystem, stringent...0 Yorumlar 0 hisse senetleri 918 Views 0 önizleme
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Yorumlar 0 hisse senetleri 543 Views 0 önizleme